ANTEOTECH LTD — AGM Information 2017

Oct 18, 2017

==> picture [185 x 103] intentionally omitted <==

Anteo Diagnostics Limited

(ABN 75 070 028 625)

SUPPLEMENT TO NOTICE OF ANNUAL GENERAL MEETING

Notice was given on 16 October 2017 that the Annual General Meeting of Shareholders of Anteo Diagnostics Ltd (“ Anteo ” or the “ Company ”) for 2017 will be held on Thursday, 16 November 2017 at 10.30 am (Sydney time) at the offices of ClarkeKann Lawyers, Level 4, 9 Castlereagh Street, Sydney .

This Notice (“ Supplementary Notice ”) supplements the Notice of Annual General Meeting, and should be read in conjunction with it.

Other than set out below, all details in relation to the Notice and Explanatory Memorandum remain unchanged.

Unless otherwise indicated, the terms defined and used in the Notice have the same meaning in this Supplementary Notice.

BUSINESS

RESOLUTION 5: RE-ELECTION OF DIRECTOR (Mr Matthew Sanderson)

To consider and, if thought fit, to pass the following resolution as an ordinary resolution:

“That Mr Matthew Sanderson, who retires in accordance with the Company’s Constitution and, being eligible, offers himself for re-election, is hereby re-elected a director of the Company”. .

DATED : 19 October 2017.

By order of the Board.

Julien McInally Company Secretary

IMPORTANT INFORMATION ABOUT PROXY VOTING

A replacement proxy form accompanies this Supplementary Notice. If you use this proxy form, it will replace and supersede any earlier proxy form that has already been provided to the Company. If you wish to direct your proxy how to vote, you should include a direction in relation to each resolution that you would like to direct your proxy (including the resolutions that you directed your proxy how to vote on in any proxy form previously delivered to the Company). If you have already delivered a valid proxy form to the Company, and do not deliver a replacement proxy form to the Company, your earlier proxy form will remain valid (but it will not include any direction to your proxy as to how to vote on Resolution 5).

Proxies must be received by the Company no later than 10.30am (Sydney time) on Tuesday 14 November 2017.

SUPPLEMENTARY EXPLANATORY MEMORANDUM

ANTEO DIAGNOSTICS LIMITED

RESOLUTION 5: RE-ELECTION OF DIRECTOR (Mr Matthew Sanderson)

The Directors appointed Mr Matthew Sanderson as a director of the Company on 19 October 2017. Under the Company’s Constitution, if a Director is appointed to the Board by the other Directors, then that Director must retire from office at, and is eligible for re-election at, the next annual general meeting following their appointment. Accordingly Mr Sanderson retires and seeks re-election to the Board.

Mr Sanderson has held various roles in his career including being involved in private investment companies, Tagrich Capital Pty Ltd, Twinvest Holdings Pty Ltd and Twinfitness Pty Ltd

Directors’ Recommendation

The Directors (other than Mr Sanderson) unanimously recommend that Shareholders vote in favour of the re-election of Mr Sanderson.

==> picture [165 x 98] intentionally omitted <==

All Correspondence to:

 By Mail Boardroom Pty Limited GPO Box 3993 Sydney NSW 2001 Australia

 By Fax: +61 2 9290 9655

 Online: www.boardroomlimited.com.au

 By Phone: (within Australia) 1300 737 760 (outside Australia) +61 2 9290 9600

YOUR VOTE IS IMPORTANT

For your vote to be effective it must be recorded before 10.30am (Sydney Time) on Tuesday 14 November 2017.

 TO VOTE ONLINE

STEP 1: VISIT www.votingonline.com.au/anteoagm2017 STEP 2: Enter your Postcode OR Country of Residence (if outside Australia) STEP 3: Enter your Voting Access Code (VAC):

.

==> picture [16 x 16] intentionally omitted <==

BY SMARTPHONE

==> picture [66 x 66] intentionally omitted <==

Scan QR Code using smartphone QR Reader App

TO VOTE BY COMPLETING THE REPLACEMENT PROXY FORM

STEP 1 APPOINTMENT OF PROXY

Indicate who you want to appoint as your Proxy.

If you wish to appoint the Chair of the Meeting as your proxy, mark the box. If you wish to appoint someone other than the Chair of the Meeting as your proxy please write the full name of that individual or body corporate. If you leave this section blank, or your named proxy does not attend the meeting, the Chair of the Meeting will be your proxy. A proxy need not be a security holder of the company. Do not write the name of the issuer company or the registered securityholder in the space.

Appointment of a Second Proxy

You are entitled to appoint up to two proxies to attend the meeting and vote. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by contacting the company’s securities registry or you may copy this form.

To appoint a second proxy you must: (a) complete two Proxy Forms. On each Proxy Form state the percentage of your voting rights or the number of securities applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded. (b) return both forms together in the same envelope.

STEP 2 VOTING DIRECTIONS TO YOUR PROXY

To direct your proxy how to vote, mark one of the boxes opposite each item of business. All your securities will be voted in accordance with such a direction unless you indicate only a portion of securities are to be voted on any item by inserting the percentage or number that you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on a given item, your proxy may vote as he or she chooses. If you mark more than one box on an item for all your securities your vote on that item will be invalid.

Proxy which is a Body Corporate

Where a body corporate is appointed as your proxy, the representative of that body corporate attending the meeting must have provided an “Appointment of Corporate Representative” prior to admission. An Appointment of Corporate Representative form can be obtained from the company’s securities registry.

STEP 3 SIGN THE FORM

The form must be signed as follows: Individual: This form is to be signed by the securityholder.

Joint Holding : where the holding is in more than one name, all the securityholders should sign.

Power of Attorney: to sign under a Power of Attorney, you must have already lodged it with the registry. Alternatively, attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: this form must be signed by a Director jointly with either another Director or a Company Secretary. Where the company has a Sole Director who is also the Sole Company Secretary, this form should be signed by that person. Please indicate the office held by signing in the appropriate place.

STEP 4 LODGEMENT

Proxy forms (and any Power of Attorney under which it is signed) must be received no later than 48 hours before the commencement of the meeting, therefore by 10:30am (Sydney Time) on Tuesday 14 November 2017. Any Proxy Form received after that time will not be valid for the scheduled meeting.

Proxy forms may be lodged using the enclosed Reply Paid Envelope or:

 Online www.votingonline.com.au/anteoagm2017  By Fax + 61 2 9290 9655  By Mail Boardroom Pty Limited GPO Box 3993, Sydney NSW 2001 Australia  In Person Boardroom Pty Limited Level 12, 225 George Street, Sydney NSW 2000 Australia

Attending the Meeting

If you wish to attend the meeting please bring this form with you to assist registration .

Anteo Diagnostics Limited ABN 75 070 028 625

Your Address

This is your address as it appears on the company’s share register. If this is incorrect, please mark the box with an “X” and make the correction in the space to the left. Securityholders sponsored by a broker should advise their broker of any changes. Please note, you cannot change ownership of your securities using this form.

REPLACEMENT PROXY FORM

STEP 1 APPOINT A PROXY

I/We being a member/s of Anteo Diagnostics Limited (Company) and entitled to attend and vote hereby appoint:

the Chair of the Meeting (mark box)

OR if you are NOT appointing the Chair of the Meeting as your proxy, please write the name of the person or body corporate (excluding the registered shareholder) you are appointing as your proxy below

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chair of the Meeting as my/our proxy at the Annual General Meeting of the Company to be held at ClarkeKann Lawyers, Level 4, 9 Castlereagh Street, Sydney NSW 2000 on Thursday, 16 November 2017 at 10:30am (Sydney Time) and at any adjournment of that meeting, to act on my/our behalf and to vote in accordance with the following directions or if no directions have been given, as the proxy sees fit.

Chair of the Meeting authorised to exercise undirected proxies on remuneration related matters: If I/we have appointed the Chair of the Meeting as my/our proxy or the Chair of the Meeting becomes my/our proxy by default and I/we have not directed my/our proxy how to vote in respect of Resolutions 1,4, I/we expressly authorise the Chair of the Meeting to exercise my/our proxy in respect of these Resolutions even though Resolutions 1,4 are connected with the remuneration of a member of the key management personnel for the Company.

The Chair of the Meeting will vote all undirected proxies in favour of all Items of business (including Resolutions 1,4). If you wish to appoint the Chair of the Meeting as your proxy with a direction to vote against, or to abstain from voting on an item, you must provide a direction by marking the 'Against' or 'Abstain' box opposite that resolution.

STEP 2

VOTING DIRECTIONS

• If you mark the Abstain box for a particular item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your vote will not be counted in calculating the required majority if a poll is called.

For Against Abstain*

Resolution 1 Adoption of Directors’ Remuneration Report Resolution 2 Re-Election of Director (Mr Alan Studley) Resolution 3 Re-Election of Director (Dr Geoff Cumming) Resolution 4 Issues of Securities under Executive/Employee Share Plan Resolution 5 Re-Election of Director (Mr Matthew Sanderson)

==> picture [96 x 131] intentionally omitted <==

STEP 3 SIGNATURE OF SHAREHOLDERS

This form must be signed to enable your directions to be implemented.

Individual or Securityholder 1 Securityholder 2 Securityholder 3 Sole Director and Sole Company Secretary Director Director / Company Secretary Contact Name…………………………………………….... Contact Daytime Telephone………………………................................ Date / / 2017